No takes yet. Share an insight, caveat, or question.
Randomized trial reveals improved oxygen saturation in children with sickle cell disease, suggesting hydroxyurea's therapeutic benefits.
Thomas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: